Crosstalk between activated and inactivated c-Src in hepatocellular carcinoma

Disease Markers

Volumn 30, Issue 6, 2011, Pages 325-333

  Chen, Mei Lin ^a   Chai, Chee Yin ^b,c   Yeh, Kun Tu ^a   Wang, Shen Nien ^b,d   Tsai, Chia Jung ^d,e   Yeh, Yao Tsung ^e   Yang, Sheau Fang ^b,c  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e FOOYIN UNIVERSITY   (Taiwan)

Author keywords

c Src; Hepatocellular carcinoma; phosphorylation status

Indexed keywords

TUMOR MARKER; TYROSINE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; GENE ACTIVATION; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; ONCOGENE SRC; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SURVIVAL RATE;

HEPATITIS C VIRUS;

EID: 79960722033     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0792     Document Type: Article

References (27)

1. R. Jove, S. Kornbluth and S. Hanafusa, Enzymatically inactive p60c-src mutant with altered ATP-binding site is fully phosphorylated in its carboxy-terminal regulatory region, Cell 50(6) (11 Sep 1987), 937-943.
2. Y. Ito, H. Kawakatsu, T. Takeda, T. Sakon, T. Nagano, T. Sakai, E. Miyoshi, K. Noda, M. Tsujimoto, K. Wakasa, K. Monden and N. Matsuura, Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype, J Hepatol 35(1) (Jul 2001), 68-73. (Pubitemid 32646226)
3. J.B. Bolen, N. Rosen and M.A. Israel, Increased pp60c-src tyrosyl kinase activity in human neuroblastomas is associated with amino-terminal tyrosine phosphorylation of the src gene product, Proc Natl Acad Sci U S A 82(21) (Nov 1985), 7275-7279. (Pubitemid 16193724)
4. J.B. Bolen, J.B. Veillette, A.M. Schwartz, A.M. De Seau and N. Rosen, Activation of pp60c-src protein kinase activity in human colon carcinoma, Proc Natl Acad Sci U S A 84(8) (Apr 1987), 2251-2255. (Pubitemid 17075849)
5. C.A. Cartwright, A.I. Meisler and W. Eckhart, Activation of the pp60c-src protein kinase is an early event in colonic car-cinogenesis, Proc Natl Acad Sci U S A 87(2) (Jan 1990), 558-562.
6. M.S. Talamonti, M.S. Roh, S.A. Curley and G.E. Gallick, Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer, J Clin Invest 91(1) (Jan 1993), 53-60. (Pubitemid 23037252)
7. N. Rosen, J.B. Bolen, A.M. Schwartz, P. Cohen, V. De Seau and M.A. Israel, Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues, J Biol Chem 261(29) (15 Oct 1986), 13754-13759. (Pubitemid 17196400)
8. T. Sakai, H. Kawakatsu, H. Fujita, H. Yano and M.K. Owada, An epitope localized in c-Src negative regulatory domain is a potential marker in early stage of colonic neoplasms, Lab Invest 78(2) (Feb 1998), 219-225. (Pubitemid 28113461)
9. T. Masaki, M. Okada, Y. Shiratori, W. Rengifo, K. Matsumoto, K. Maeda, K. Kato, K. Kanai, Y. Komatsu, Y. Nishioka and Y. Omata, pp60c-src activation in hepatocellular carcinoma of humans and LEC rats, Hepatology 27(5) (May 1998), 1257-1264. (Pubitemid 28227852)
10. C.K. Sun, K. Man, K.T. Ng, J.W. Ho, Z.X. Lim, Q. Cheng, C.M. Lo, R.T. Poon and S.T. Fan, Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepato-cellular carcinoma cells through c-Src/ERK activation, Car-cinogenesis 29(11) (Nov 2008), 2096-2105.
11. E.N. De Toni, S.E. Thieme, A. Herbst, A. Behrens, A. Stieber, A. Jung, H. Blum, H. Goke and F.T. Kolligs, OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer, Clin Cancer Res 14(15) (1 Aug 2008), 4713-4718.
12. T. Hunter, A tail of two src's: mutatis mutandis, Cell 49(1) (10 Apr 1987), 1-4.
13. R. Roskoski, Jr., Src protein-tyrosine kinase structure and regulation, Biochem Biophys Res Commun 324(4) (26 Nov 2004), 1155-1164.
14. N.M. Levinson, M.A. Seeliger, P.A. Cole and J. Kuriyan, Structural basis for the recognition of c-Src by its inactivator Csk, Cell 134(1) (11 Jul 2008), 124-134. (Pubitemid 351916707)
15. T. Nakagawa, S. Tanaka, S. Suzuki, S. Takayanagi, S. Miyaza-ki, S. Nakamura and S. Tsuruo, Overexpression of the csk gene suppresses tumor metastasis in vivo, Int J Cancer 88(3) (1 Nov 2000), 384-391.
16. S. Shenoy, I. Chackalaparampil, I. Bagrodia, P.H. Lin and D. Shalloway, Role of p34cdc2-mediated phosphorylations in two-step activation of pp60c-src during mitosis, Proc Natl Acad Sci U S A 89(15) (1 Aug 1992), 7237-7241.
17. J.A. Cooper, K.L. Gould, C.A. Cartwright and C.A. Hunter, Tyr527 is phosphorylated in pp60c-src: implications for regulation, Science 231(4744) (21 Mar 1986), 1431-1434.
18. T.E. Kmiecik and D. Shalloway, Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation, Cell 49(1) (10 Apr 1987), 65-73.
19. M. Vidal, S. Warner, S. Read and R.L. Cagan, Differing Src signaling levels have distinct outcomes in Drosophila, Cancer Res 67(21) (1 Nov 2007), 10278-10285. (Pubitemid 350070801)
20. The general rules for the clinical and pathological study of primary liver cancer, Liver Cancer Study Group of Japan, Jpn J Surg 19(1) (Jan 1989), 98-129.
21. Y.T. Yeh, F. Ou-Yang, I.F. Chen, S.F. Yang, J.H. Su, M.F. Hou and S.S. Yuan, Altered p-JAK1 expression is associated with estrogen receptor status in breast infiltrating ductal carcinoma, Oncol Rep 17(1) (Jan 2007), 35-39.
22. S.N. Wang, Y.T. Yeh, S.F. Yang, C.Y. Chai and K.T. Lee, Potential role of leptin expression in hepatocellular carcinoma, J Clin Pathol 59(9) (Sep 2006), 930-934.
23. S.N. Wang, Y.T. Yeh, M.L. Yu, C.L. Wang and K.T. Lee, Serum adiponectin levels in cholesterol and pigment cholelithiasis, Br J Surg 93(8) (Aug 2006), 981-986.
24. S.F. Yang, S.N. Wang, C.F. Wu, Y.T. Yeh, C.Y. Chai, S.C. Chunag, M.C. Sheen and K.T. Lee, Altered p-STAT3 (tyr705) expression is associated with histological grading and intratu-mour microvessel density in hepatocellular carcinoma, J Clin Pathol 60(6) (Jun 2007), 642-648.
25. N.P. Klein, M.J. Bouchard, L.H. Wang, L.H. Kobarg and R.J. Schneider, Src kinases involved in hepatitis B virus replication, EMBO J 18(18) (15 Sep 1999), 5019-5027. (Pubitemid 29443804)
26. X.M. Zheng, R.J. Resnick and D.A. Shalloway, phosphotyro-sine displacement mechanism for activation of Src by PTPal-pha, EMBO J 19(5) (1 Mar 2000), 964-978. (Pubitemid 30119822)
27. N.P. Klein and R.J. Schneider, Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras, Mol Cell Biol 17(11) (Nov 1997), 6427-6436. (Pubitemid 27451188)